share_log
Reuters ·  May 8 07:03
Verve Therapeutics Inc - Cash, Cash Equivalents and Marketable Securities of $606.4 Mln; Cash Runway Into Late 2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment